ArticleACS pharmacology & translational science2022

Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling.

Aric Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.